Inmune Bio, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Inmune Bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Inmune Bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$2.5M.
  • Inmune Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$4.23M, a 680% decline from 2022.
  • Inmune Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $729K, a 99.2% decline from 2021.
  • Inmune Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $96.4M, a 303% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4.23M -$4.95M -680% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $729K -$95.6M -99.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $96.4M +$72.5M +303% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $23.9M +$11.7M +95.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 $12.2M +$11.3M +1257% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 $900K -$1.16M -56.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 $2.06M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.